SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : A BIOTECHNOLOGY STOCK WITH A FUTURE - GENETIC VECTORS

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Drewitz who wrote (28)12/3/1997 8:43:00 PM
From: william allen  Read Replies (1) of 52
 
Jim,
Sorry for not responding sooner, my main question remain is, what effect will the sell off of the Nyer held shares have on the growth and stock price over the next 18 months. The CFO at NYER still claims that their are no restrictions on their selling and they will begin selling down to the 20% that their auditors reccommend. Will this effect their R&D and the anticipated food and beverage test. Also who is Jeff Taylor, that is not a name that comes to mind with regards to GVEC.
How was your Thansgiving, noticed you took a long weekend from all this stock chatter.
Rdgs, Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext